Oppenheimer Reiterates Outperform Rating on Clene (CLNN), Sees ALS Readout as Coming Next Quarter
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $19.00 price target on Clene, Inc. (NASDAQ: CLNN).The analyst comments: "From ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
